THOMAS KOSTEN to Monoamine Oxidase Inhibitors
This is a "connection" page, showing publications THOMAS KOSTEN has written about Monoamine Oxidase Inhibitors.
Connection Strength
0.051
-
A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation. Biol Psychiatry. 2003 Jan 15; 53(2):136-43.
Score: 0.051
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.